Effects of Treatments on Atopic Dermatitis
NCT01631617
This study is recruiting at 1 US site in 1 state, according to its ClinicalTrials.gov record last updated .
Summary
Background: - Atopic dermatitis, or eczema, is a chronic skin disorder. Patients sometimes have infections with S. aureus bacteria. Researchers want to study how eczema treatments affect the number and the type of bacteria on the skin. Objectives: - To study the effect of eczema treatments on skin bacteria. Eligibility: Individuals between 2 and 25 years of age who have moderate to severe atopic dermatitis. Healthy volunteers between 18 and 40 years of age with no history of eczema. Design: Participants will be screened with a physical exam and medical history.
Shortened from the sponsor's brief summary. View official record on ClinicalTrials.gov
Conditions studied
- Eczema
- Dermatitis
- Skin Diseases, Genetic
- Dermatitis, Atopic
- Skin Diseases
Eligibility basics and study details
- Study type
- Interventional
- Phase
- Phase 2
- Ages
- 2 to 50 years
- Sex
- All
- Healthy volunteers
- Accepted
- Sponsor
- National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)
- Last updated on ClinicalTrials.gov
- September 28, 2026
These are the basic criteria only. The full inclusion and exclusion criteria are on the official record, and the study team decides who can take part.
US recruiting sites
Maryland · 1
- National Institutes of Health Clinical Center · Bethesda, MD
Source: ClinicalTrials.gov, data processed . Recruiting US sites filtered by distance and site status; summaries shortened.